title: Mobile Phone Messaging During Unobserved "Home" Induction to Buprenorphine.
abstract: The deployment of health information technologies promises to optimize clinical outcomes for populations with substance use disorders. Electronic health records, web-based counseling interventions, and mobile phone applications enhance the delivery of evidence-based behavioral and pharmacological treatments, with minimal burden to clinical personnel, infrastructure, and work flows. This clinical case shares a recent experience utilizing mobile phone text messaging between an office-based buprenorphine provider in a safety net ambulatory clinic and a patient seeking buprenorphine treatment for opioid use disorder. The case highlights the use of text message-based physician-patient communication to facilitate unobserved "home" induction onto buprenorphine.
authors.affiliation: Department of Population Health, New York University School of Medicine (BT, SS, JDL); Department of Medicine, Division of General Internal Medicine, New York University School of Medicine (BT, EG, SS, JDL); Department of Psychiatry, New York University School of Medicine (SS); New York State Psychiatric Institute, (EVN); and Columbia University Department of Psychiatry, (EVN), New York, NY.
authors.forename: Babak
authors.initials: B
authors.lastname: Tofighi
authors.forename: Ellie
authors.initials: E
authors.lastname: Grossman
authors.forename: Scott
authors.initials: S
authors.lastname: Sherman
authors.forename: Edward V
authors.initials: EV
authors.lastname: Nunes
authors.forename: Joshua D
authors.initials: JD
authors.lastname: Lee
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use*; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods* / Q000592:standards; D060145:Text Messaging / Q000592:standards / Q000706:statistics & numerical data*
chemical_list: D009292:Narcotic Antagonists; D002047:Buprenorphine